ImageneBio, Inc.
IMA
$6.63
$0.426.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 568.44% | -10.69% | 12.54% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 380.38% | 15.25% | -69.72% | ||
| Operating Income | -1,206.19% | -15.25% | 73.28% | ||
| Income Before Tax | -680.80% | -21.19% | 72.77% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -678.48% | -21.19% | 72.77% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -678.48% | -21.19% | 72.77% | ||
| EBIT | -1,206.19% | -15.25% | 73.28% | ||
| EBITDA | -1,255.35% | -23.94% | 72.56% | ||
| EPS Basic | 31.90% | 18.64% | 74.71% | ||
| Normalized Basic EPS | -28.25% | 15.80% | 81.11% | ||
| EPS Diluted | 31.90% | 18.64% | 74.71% | ||
| Normalized Diluted EPS | -28.25% | 15.80% | 81.11% | ||
| Average Basic Shares Outstanding | 508.80% | 43.92% | 43.76% | ||
| Average Diluted Shares Outstanding | 508.80% | 43.92% | 43.76% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||